Ken Griffin Biotechnology

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
AGIO
Agios Pharmaceuticals, Inc.
CALL
$308,000
9.4K
Q4 2024
Added 12116.05%
VERA
Vera Therapeutics, Inc.
CALL
$304,000
7.2K
Q4 2024
Added 1685.21%
CABA
Cabaletta Bio, Inc.
CALL
$300,000
136K
Q3 2024
Reduced 98.59%
CHRS
Coherus Bio Sciences, Inc.
CALL
$297,000
216K
Q3 2024
Added 0.48%
TARA
Protara Therapeutics, Inc.
PUT
$296,000
56.4K
Q4 2024
Added 50.99%
VCEL
Vericel Corp
PUT
$296,000
5.4K
Q4 2024
Reduced 88.09%
MREO
Mereo Biopharma Group PLC
CALL
$293,000
83.9K
Q4 2024
Added 141.02%
INMB
Inmune Bio, Inc.
CALL
$291,000
62.5K
Q4 2024
Added 13.19%
IMCR
Immunocore Holdings PLC
PUT
$286,000
9.7K
Q4 2024
Added 28.02%
CPRX
Catalyst Pharmaceuticals, Inc.
CALL
$279,000
13.4K
Q4 2024
Added 1629.4%
NKTX
Nkarta, Inc.
PUT
$270,000
109K
Q4 2024
Added 13.55%
EYPT
Eye Point Pharmaceuticals, Inc.
PUT
$268,000
36K
Q4 2024
Added 75.28%
GMAB
Genmab A/S
PUT
$267,000
12.8K
Q4 2024
Added 137.88%
RANI
Rani Therapeutics Holdings, Inc.
PUT
$264,000
193K
Q4 2024
Added 342.19%
CGEM
Cullinan Oncology, Inc.
CALL
$263,000
21.6K
Q4 2024
Added 37.21%
FDMT
4 D Molecular Therapeutics, Inc.
CALL
$256,000
46.1K
Q4 2024
Added 374.03%
RGNX
Regenxbio Inc.
PUT
$245,000
31.7K
Q4 2024
Added 188.05%
CPRX
Catalyst Pharmaceuticals, Inc.
PUT
$244,000
11.7K
Q4 2024
Added 1629.4%
BMEA
Biomea Fusion, Inc.
PUT
$239,000
61.6K
Q4 2024
Added 173791.11%
OCGN
Ocugen, Inc.
CALL
$239,000
300K
Q4 2024
New holding
IGMS
Igm Biosciences, Inc.
CALL
$238,000
39.1K
Q2 2024
Reduced 84.97%
PTCT
Ptc Therapeutics, Inc.
PUT
$234,000
5.2K
Q4 2024
Added 91.53%
DAWN
Day One Biopharmaceuticals, Inc.
CALL
$233,000
18.4K
Q4 2024
Added 26.24%
SLS
Sellas Life Sciences Group, Inc.
CALL
$228,000
226K
Q4 2024
Added 925.63%
ENOB
Enochian Biosciences Inc
PUT
$226,000
49.2K
Q4 2023
Added 50.32%
PLRX
Pliant Therapeutics, Inc.
CALL
$222,000
16.9K
Q4 2024
Added 1045.91%
KROS
Keros Therapeutics, Inc.
CALL
$221,000
14K
Q4 2024
Added 12.23%
KYMR
Kymera Therapeutics, Inc.
PUT
$221,000
5.5K
Q4 2024
Reduced 4.51%
ETNB
89bio, Inc.
CALL
$220,000
28.8K
Q4 2024
Added 85.0%
DYN
Dyne Therapeutics, Inc.
PUT
$216,000
9.2K
Q4 2024
Reduced 2.65%
IMNM
Immunome Inc.
CALL
$216,000
21.1K
Q4 2024
New holding
CDXC
Chroma Dex Corp.
CALL
$214,000
40.4K
Q4 2024
Added 8712.91%
KOD
Kodiak Sciences Inc.
PUT
$210,000
21.2K
Q3 2024
New holding
TRVI
Trevi Therapeutics, Inc.
PUT
$210,000
49.5K
Q4 2024
Added 2372.24%
KOD
Kodiak Sciences Inc.
CALL
$209,000
21.1K
Q3 2024
New holding
VIR
Vir Biotechnology, Inc.
PUT
$209,000
28.6K
Q4 2024
Added 0.85%
MRUS
Merus N.V.
CALL
$206,000
4.9K
Q4 2024
Reduced 96.3%
MCRB
Seres Therapeutics, Inc.
CALL
$206,000
249K
Q4 2024
New holding
FOLD
Amicus Therapeutics, Inc.
CALL
$203,000
21.6K
Q4 2024
Added 126.99%
CMRX
Chimerix Inc
PUT
$202,000
58.3K
Q4 2024
Reduced 31.56%
APLT
Applied Therapeutics Inc.
PUT
$200,000
235K
Q4 2024
Added 105.84%
INVA
Innoviva, Inc.
CALL
$199,000
11.5K
Q4 2024
Reduced 35.41%
ABSI
Absci Corp
CALL
$193,000
73.8K
Q4 2024
New holding
MDXG
Mimedx Group, Inc.
PUT
$192,000
20K
Q4 2024
Reduced 0.03%
MGTX
Meira G Tx Holdings PLC
PUT
$187,000
30.8K
Q4 2024
Added 10.21%
FDMT
4 D Molecular Therapeutics, Inc.
PUT
$182,000
32.7K
Q4 2024
Added 374.03%
NRIX
Nurix Therapeutics, Inc.
PUT
$182,000
9.7K
Q4 2024
Reduced 44.39%
APLT
Applied Therapeutics Inc.
CALL
$171,000
201K
Q4 2024
Added 105.84%
PSTX
Poseida Therapeutics, Inc.
CALL
$169,000
17.7K
Q4 2024
New holding
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email